| Round 1 | Round 2 | ||
---|---|---|---|---|
N | % | N | % | |
Gender | ||||
 Male | 36 | 68% | 31 | 72% |
 Female | 17 | 32% | 12 | 28% |
Years of relevant work experience | ||||
 5–10 years | 4 | 8% | 4 | 9% |
  > 10—20 years | 16 | 30% | 12 | 28% |
  > 20 years | 33 | 62% | 27 | 63% |
Affiliationa | ||||
 Academic institution | 22 | 42% | 18 | 42% |
 Research institution | 10 | 19% | 9 | 21% |
 Government agency | 6 | 11% | 6 | 14% |
 Non-governmental organization | 12 | 23% | 11 | 26% |
 Donor agency | 5 | 9% | 3 | 7% |
 UN Agency | 4 | 8% | 4 | 9% |
 Private sector | 3 | 6% | 2 | 5% |
 Other | 4 | 8% | 4 | 9% |
Area of worka | ||||
 Health economics | 3 | 6% | 3 | 7% |
 Regulation | 3 | 6% | 2 | 5% |
 Market access | 4 | 8% | 3 | 7% |
 Malaria treatment | 33 | 62% | 30 | 70% |
 Drug development | 10 | 19% | 8 | 19% |
 Supply chains | 4 | 8% | 3 | 7% |
 Drug resistance research | 24 | 45% | 20 | 47% |
 Policy making | 12 | 23% | 9 | 21% |
 Other | 7 | 13% | 4 | 9% |
Affiliated to the DeTACTb project | ||||
 No | 42 | 79% | 32 | 74% |
 Yes | 11 | 21% | 11 | 26% |
Country of residencec | ||||
 Australia | 3 | 6% | 2 | 5% |
 Bangladesh | 1 | 2% | 1 | 2% |
 Belgium | 1 | 2% | 1 | 2% |
 Brazil | 1 | 2% | - | - |
 Cambodia | 4 | 8% | 4 | 9% |
 China | 2 | 4% | 2 | 5% |
 France | 1 | 2% | 1 | 2% |
 Germany | 1 | 2% | 1 | 2% |
 Indonesia | 3 | 6% | 2 | 5% |
 Kenya | 1 | 2% | 1 | 2% |
 Lao PDR | 2 | 4% | 2 | 5% |
 Myanmar | 5 | 9% | 4 | 9% |
 Nigeria | 1 | 2% | 1 | 2% |
 Philippines | 1 | 2% | - | - |
 Portugal | 1 | 2% | 1 | 2% |
 Switzerland | 5 | 9% | 5 | 12% |
 Thailand | 10 | 19% | 8 | 19% |
 UK | 1 | 2% | 1 | 2% |
 USA | 8 | 15% | 5 | 12% |
 Vietnam | 1 | 2% | 1 | 2% |